Evidence map›Paper›PMID 34194532›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2021

Leishmanicidal Activity and Ultrastructural Changes of Maslinic Acid Isolated from

Jéssica Adriana Jesus, Márcia Dalastra Laurenti, Matheus Lopes Silva, João Henrique Ghilardi Lago, Luiz Felipe Domingues Passero

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. High Selectivity of 8-Hydroxyquinoline onPharmaceuticals (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Jéssica Adriana JesusLaboratory of Pathology of Infectious Diseases (LIM50), Department of Pathology, Medical School of São Paulo University, Av. Dr. Arnaldo, 455. Cerqueira César, SP 01246-903, Brazil.ORCID https://orcid.org/0000-0002-7212-5094
Márcia Dalastra LaurentiLaboratory of Pathology of Infectious Diseases (LIM50), Department of Pathology, Medical School of São Paulo University, Av. Dr. Arnaldo, 455. Cerqueira César, SP 01246-903, Brazil.ORCID https://orcid.org/0000-0002-1080-2440
Matheus Lopes SilvaCentre of Natural and Human Sciences, Federal University of ABC (UFABC), Santo André 09210-580, Brazil.
João Henrique Ghilardi LagoCentre of Natural and Human Sciences, Federal University of ABC (UFABC), Santo André 09210-580, Brazil.
Luiz Felipe Domingues PasseroSão Paulo State University (UNESP), Institute of Biosciences, São Vicente. Praça Infante Dom Henrique, s/n, São Vicente, SP 11330-900, Brazil.ORCID https://orcid.org/0000-0002-5986-6381
Universidade de São Paulo · BRUniversidade Federal do ABC · BRUniversidade Estadual Paulista (Unesp) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The therapeutic arsenal for the treatment of leishmaniasis is limited and has serious obstacles, such as variable activity, high toxicity, and costs. To overcome such limitations, it becomes urgent to characterize new bioactive molecules. Plants produce and accumulate different classes of bioactive compounds, and these molecules can be studied as a strategy to combat leishmaniasis. The study presented herein evaluated the leishmanicidal effect of maslinic acid isolated from the leaves of

Identifiers

PMID34194532
PMCPMC8184317
OpenAlexW3170696276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.